Viking Therapeutics shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Viking Therapeutics (VKTX) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Viking Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Viking Therapeutics held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Viking Therapeutics by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $10M | 158k | 63.31 |
| 2024-06-30 | $2.6M | 50k | 53.01 |
| 2023-09-30 | $845k | 76k | 11.07 |
| 2023-06-30 | $3.2M | 197k | 16.21 |
| 2023-03-31 | $1.5M | 90k | 16.65 |
| 2022-12-31 | $830k | 88k | 9.40 |
| 2022-09-30 | $707k | 260k | 2.72 |
| 2022-06-30 | $644k | 223k | 2.89 |
| 2022-03-31 | $356k | 119k | 3.00 |
| 2021-12-31 | $180k | 39k | 4.59 |
| 2021-09-30 | $150k | 24k | 6.26 |
| 2021-06-30 | $84k | 14k | 6.00 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management